Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC.
Clinical trial NCT04730544 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04730544
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-21
- Primary completion
- 2027-04-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.